| 1 | NV NVSEF•US•PINK $290.05B·$150.19·-6.24% | | $290.05B | $150.19 | -6.24% | - | |
| 2 | TE Teva Pharmaceutical Industries Limited TEVJF•US•PINK $52.06B·$28.36·+0.00% | | $52.06B | $28.36 | +0.00% | - | |
| 3 | ON ONC•US•NASDAQ $31.55B·$275.69·-2.34% | | $31.55B | $275.69 | -2.34% | 209.3K | |
| 4 | UT United Therapeutics Corporation UTHR•US•NASDAQ $22.98B·$531.82·+0.28% | | $22.98B | $531.82 | +0.28% | 539.6K | |
| 5 | GN GNMSF•US•PINK $16.40B·$274.75·-0.20% | | $16.40B | $274.75 | -0.20% | - | |
| 6 | GM GMAB•US•NASDAQ $15.50B·$25.81·-0.15% | | $15.50B | $25.81 | -0.15% | 1.6M | |
| 7 | SM SMMT•US•NASDAQ $12.10B·$15.54·-0.38% | | $12.10B | $15.54 | -0.38% | 2.0M | |
| 8 | IO Ionis Pharmaceuticals Inc IONS•US•NASDAQ $11.73B·$69.68·-2.80% | | $11.73B | $69.68 | -2.80% | 1.8M | |
| 9 | MD Madrigal Pharmaceuticals Inc MDGL•US•NASDAQ $10.27B·$445.04·+0.69% | | $10.27B | $445.04 | +0.69% | 197.8K | |
| 10 | PR Praxis Precision Medicines Inc PRAX•US•NASDAQ $8.31B·$294.65·+2.03% | | $8.31B | $294.65 | +2.03% | 489.9K | |
| 11 | PT PTCT•US•NASDAQ $5.50B·$64.54·-3.67% | | $5.50B | $64.54 | -3.67% | 1.0M | |
| 12 | FO FOLD•US•NASDAQ $4.53B·$14.41·+0.28% | | $4.53B | $14.41 | +0.28% | 3.1M | |
| 13 | LG Ligand Pharmaceuticals Incorporated LGND•US•NASDAQ $4.00B·$201.66·-3.75% | | $4.00B | $201.66 | -3.75% | 201.7K | |
| 14 | LQ Liquidia Technologies Inc LQDA•US•NASDAQ $3.13B·$35.20·-3.90% | | $3.13B | $35.20 | -3.90% | 632.5K | |
| 15 | MA Veradermics, Incorporated MANE•US•NYSE $2.17B·$63.49·+7.59% | | $2.17B | $63.49 | +7.59% | 538.6K | |
| 16 | GL GLPG•US•NASDAQ $2.11B·$29.80·-7.37% | | $2.11B | $29.80 | -7.37% | 617.4K | |
| 17 | ZY Zymeworks Inc. Common Stock ZYME•US•NASDAQ $1.73B·$23.60·+0.64% | | $1.73B | $23.60 | +0.64% | 480.4K | |
| 18 | HR Harmony Biosciences Holdings HRMY•US•NASDAQ $1.60B·$27.10·-2.69% | | $1.60B | $27.10 | -2.69% | 1.1M | |
| 19 | NU NUVB•US•NYSE $1.47B·$4.28·+0.00% | | $1.47B | $4.28 | +0.00% | 2.9M | |
| 20 | RA Rapport Therapeutics, Inc. Common Stock RAPP•US•NASDAQ $1.33B·$28.25·+6.68% | | $1.33B | $28.25 | +6.68% | 189.3K | |
| 21 | PR PRGO•US•NYSE $1.32B·$9.64·-3.02% | | $1.32B | $9.64 | -3.02% | 2.5M | |
| 22 | HR HROW•US•NASDAQ $1.24B·$35.20·+2.09% | | $1.24B | $35.20 | +2.09% | 511.3K | |
| 23 | IV IVA•US•NASDAQ $1.20B·$6.02·+1.01% | | $1.20B | $6.02 | +1.01% | 69.7K | |
| 24 | IV IVEVF•US•PINK $921.96M·$4.44·+0.00% | | $921.96M | $4.44 | +0.00% | - | |
| 25 | JA JANX•US•NASDAQ $845.56M·$13.56·-2.16% | | $845.56M | $13.56 | -2.16% | 1.2M | |
| 26 | SP SPRY•US•NASDAQ $761.61M·$7.54·-9.16% | | $761.61M | $7.54 | -9.16% | 2.5M | |
| 27 | MN MNKD•US•NASDAQ $761.01M·$2.29·-12.26% | | $761.01M | $2.29 | -12.26% | 13.7M | |
| 28 | KU KURA•US•NASDAQ $729.60M·$8.07·-3.81% | | $729.60M | $8.07 | -3.81% | 982.2K | |
| 29 | ZV ZVRA•US•NASDAQ $553.06M·$9.15·-4.19% | | $553.06M | $9.15 | -4.19% | 663.5K | |
| 30 | IR Ironwood Pharmaceuticals Inc IRWD•US•NASDAQ $536.46M·$3.04·-4.10% | | $536.46M | $3.04 | -4.10% | 1.7M | |
| 31 | IM IMMX•US•NASDAQ $482.42M·$8.57·-9.41% | | $482.42M | $8.57 | -9.41% | 599.4K | |
| 32 | PR PRTA•US•NASDAQ $471.04M·$8.73·+1.63% | | $471.04M | $8.73 | +1.63% | 534.7K | |
| 33 | UP UPB•US•NASDAQ $468.51M·$8.45·-2.48% | | $468.51M | $8.45 | -2.48% | 699.7K | |
| 34 | NA Natures Sunshine Products Inc NATR•US•NASDAQ $415.46M·$23.82·+3.57% | | $415.46M | $23.82 | +3.57% | 205.4K | |
| 35 | EL ELTP•US•OTCQB $409.26M·$0.38·-1.82% | | $409.26M | $0.38 | -1.82% | 113.2K | |
| 36 | XO XOMA•US•NASDAQ $354.43M·$29.22·+6.84% | | $354.43M | $29.22 | +6.84% | 87.9K | |
| 37 | NW Northwest Biotherapeutics Inc NWBO•US•OTCQB $323.54M·$0.21·+5.13% | | $323.54M | $0.21 | +5.13% | 934.3K | |
| 38 | IR IRD•US•NASDAQ $312.34M·$4.51·-3.22% | | $312.34M | $4.51 | -3.22% | 473.0K | |
| 39 | TH THAR•US•NASDAQ $187.37M·$3.33·-18.30% | | $187.37M | $3.33 | -18.30% | 466.9K | |
| 40 | MG MGNX•US•NASDAQ $181.77M·$2.73·-8.39% | | $181.77M | $2.73 | -8.39% | 663.1K | |
| 41 | GA Galectin Therapeutics Inc GALT•US•NASDAQ $177.32M·$2.83·+0.53% | | $177.32M | $2.83 | +0.53% | 141.8K | |
| 42 | ZN Zentalis Pharmaceuticals Llc ZNTL•US•NASDAQ $169.65M·$2.47·-1.79% | | $169.65M | $2.47 | -1.79% | 417.7K | |
| 43 | IM IMUX•US•NASDAQ $143.51M·$1.25·+8.70% | | $143.51M | $1.25 | +8.70% | 2.5M | |
| 44 | OR Oramed Pharmaceuticals Inc ORMP•US•NASDAQ $141.46M·$3.42·-4.20% | | $141.46M | $3.42 | -4.20% | 174.7K | |
| 45 | KP Karyopharm Therapeutics Inc KPTI•US•NASDAQ $139.96M·$5.44·-35.24% | | $139.96M | $5.44 | -35.24% | 17.8M | |
| 46 | VR Verrica Pharmaceuticals Inc VRCA•US•NASDAQ $83.32M·$4.48·-21.54% | | $83.32M | $4.48 | -21.54% | 141.3K | |
| 47 | PL PLRX•US•NASDAQ $79.87M·$1.28·+0.00% | | $79.87M | $1.28 | +0.00% | 352.1K | |
| 48 | RF RFL•US•NYSE $64.50M·$1.24·-3.13% | | $64.50M | $1.24 | -3.13% | 28.8K | |
| 49 | LF LFVN•US•NASDAQ $59.74M·$4.33·-6.88% | | $59.74M | $4.33 | -6.88% | 62.9K | |
| 50 | OS OS Therapies Incorporated OSTX•US•NYSE MKT $53.53M·$1.38·-8.61% | | $53.53M | $1.38 | -8.61% | 745.6K | |